On June 4, 2018, ZhongYin entered into a project-specific legal service agreement with Wuhu Tungsu Weiyu Medical Device Technology Co., Ltd. (“Tungsu Medical”). The team led by Wang Ting, Tan Jun and Wu Guanghong who are ZhongYin’s senior partners responsible for practice in the capital market, will advise Tungsu Medical on its offering of asset-backed securities to raise funds.

Tungsu Medical is a majority-owned subsidiary of Tungsu Group Co., Ltd., one of the leaders in high-end manufacturing. Up to now, it has a range of businesses, including direct sales and distribution of medical devices, centralized distribution to hospitals, basic medical services, third-party logistics, centralized procurement for groups and governments, international trades and industry consulting services. Tungsu Medical has strong financial strength and good connection with government. It has resources relating to including strategic partnership with more than ten Fortune 500 companies such as Medtronic, GE and Johnson.

The team of Wang Ting, Tan Jun and Wu Guanghong, currently consisting of nearly twenty professional lawyers, has extensive experience and a large number of successful cases in practicing in domestic and overseas IPO and listing, refinancing of listed companies, M&A, reorganization, NEEQ listing, private equity and investment fund, foreign investment, bond issuance, asset securitization, long-term legal counseling and otherwise, and has a profound understanding of PRC laws and regulations and regulatory practices, and thus can provide flexible, high-quality and value-added legal services based on the characteristics of different clients.